Stable agonist of glucose-dependent insulinotropic polypeptide (GIP) restores pancreatic beta cell glucose responsiveness but not glucose intolerance in aging mice

Experimental Gerontology

Volumn 41, Issue 2, 2006, Pages 151-156

  Irwin, Nigel ^a   Green, Brian D ^a   Gault, Victor A ^a   Harriot, Patrick ^b   O'Harte, Finbarr P M ^a   Flatt, Peter R ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Aging; Enteroinsular axis; Glucose intolerance; Insulin secretion; N AcGIP(LysPAL37)

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN;

AGING; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN RESPONSE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

AGING; ANIMALS; BLOOD GLUCOSE; EATING; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN; ISLETS OF LANGERHANS; LEPTIN; MICE; MICE, MUTANT STRAINS;

ANIMALIA;

EID: 31544465479     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2005.11.006     Document Type: Article

References (27)

1. T. Aizawa, M. Komatsu, Y. Sato, F. Ishihara, N. Suzuki, N. Nishii, K. Hashizume, and T. Yamada Insulin secretion by the pancreatic beta cell of aged rats Pancreas 9 1994 454 459
2. C.J. Bailey, and P.R. Flatt Influence of genetic background and age on the expression of the obese hyperglycemic syndrome in Aston ob/ob mice Int. J. Obes. 6 1982 11 21
3. R.S. Burington Handbook of Mathematical Tables and Formulae 1973 McGraw-Hill New York
4. A.M. Chang, and J.B. Halter Aging and insulin secretion Am. J. Physiol. Endocrinol. Metab. 284 2003 E7 E12
5. W. Creutzfeldt The entero-insular axis in type 2 diabetes-incretins as therapeutic agents Exp. Clin. Endocrinol. Diabetes 109 2001 S288 S303
6. R.A. Defronzo Glucose intolerance and aging: evidence for tissue insensitivity to insulin Diabetes 28 1979 1095 1101
7. M.E. Doyle, and J.M. Egan Glucagon-like peptide-1 Recent Prog. Horm. Res. 56 2001 377 399
8. D. Elahi, D.K. Andersen, D.C. Muller, J.D. Tobin, J.C. Brown, and R. Andres The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus Diabetes 33 1984 950 957
9. D. Elahi, D.C. Muller, D.K. Andersen, J.D. Tobin, and R. Andres The effect of age and glucose concentration on insulin secretion by the isolated perfused pancreas Endocrinology 116 1985 11 16
10. D. Elahi, D.C. Muller, J.M. Egan, R. Andres, J. Veldhuist, and G.S. Meneilly Glucose tolerance, glucose utilization and insulin secretion in ageing Novartis Found Symp. 242 2002 222 242
11. P.R. Flatt, and C.J. Bailey Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice Diabetologia 20 1981 573 577
12. V.A. Gault, J.C. Parker, P. Harriott, P.R. Flatt, and F.P.M. O'Harte Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide (GIP), GIP(3-42), is a GIP receptor antagonist in vivo J. Endocrinol. 175 2002 525 533
13. M.I. Harris, W.C. Hadden, W.C. Knowler, and P.H. Bennett Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr Diabetes 36 1987 523 534
14. M.I. Harris, K.M. Flegal, C.C. Cowie, M.S. Eberhardt, D.E. Goldstein, R.R. Little, H.M. Wiedmeyer, and D.D. Byrd-Holt Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994 Diabetes Care 21 1998 518 524
15. 37) Biol. Chem. 386 2005 679 687
16. Irwin, N., Green, B.D., Mooney, M.H., Greer, B., Harriott, P., Bailey, C.J., Gault, V.A., O'Harte, F.P.M., Flatt, P.R., 2005b. A novel, long-acting agonist of GIP suitable for once daily administration in type 2 diabetes. J. Pharm. Exp. Ther. 314, 1187-1194.
17. T.J. Kieffer, C.H.S. McIntosh, and R.A. Pedersen Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV Endocrinology 136 1995 3585 3596
18. J.T. Lewis, B. Dayanandan, J.F. Habener, and T.J. Kieffer Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist Endocrinology 141 2000 3710 3716
19. J.J. Meier, M.A. Nauck, D. Kranz, J.J. Holst, C.F. Deacon, D. Gaeckler, W.E. Schmidt, and B. Gallwitz Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects Diabetes 53 2004 654 662
20. G.S. Meneilly, H.U. Demuth, C.H. McIntosh, and R.A. Pederson Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose Diabetes. Med. 17 2000 6 30
21. R. Perfetti, C.M. Rafizadeh, A.S. Liotta, and J.M. Egan Age-dependent reduction in insulin secretion and insulin mRNA in isolated islets from rats Am. J. Physiol. 269 1995 E983 E990
22. L. Ranganath, I. Sedgwick, L. Morgan, J. Wright, and V. Marks The ageing entero-insular axis Diabetologia 41 1998 1309 1313
23. G.M. Raven Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease Am. Heart J. 121 1991 1283 1288
24. H.E. Resnick, M.I. Harris, D.B. Brock, and T.B. Harris American diabetes association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the third national health and nutrition examination survey Diabetes Care 23 2000 176 180
25. J.F. Stevens Determination of glucose by an automatic analyser Clin. Chem. Acta 32 1971 199 201
26. A. Trumper, K. Trumper, H. Trusheim, R. Arnold, B. Göke, and D. Horsch Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling Mol. Endocrinol. 15 2001 1559 1570
27. A. Trumper, K. Trumper, and D. Horsch Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells J. Endocrinol. 174 2002 233 246